AProArt-CD34

N/A

Report date: 2026/02/02 16:49:49

Base Information

Drug NameAProArt-CD34
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionProtein artemis gene transference
TargetsProtein artemis
Therapy Area/IndicationsSevere Combined Immunodeficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San Francisco
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San Francisco
Inactive CompaniesN/A
Active IndicationsSevere Combined Immunodeficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A